IE922182A1 - A process for the preparation of alkylphosphocholines and¹the production thereof in pure form - Google Patents

A process for the preparation of alkylphosphocholines and¹the production thereof in pure form

Info

Publication number
IE922182A1
IE922182A1 IE218292A IE922182A IE922182A1 IE 922182 A1 IE922182 A1 IE 922182A1 IE 218292 A IE218292 A IE 218292A IE 922182 A IE922182 A IE 922182A IE 922182 A1 IE922182 A1 IE 922182A1
Authority
IE
Ireland
Prior art keywords
preparation
ion exchanger
alkylphosphocholines
reaction
alkanol
Prior art date
Application number
IE218292A
Other versions
IE80555B1 (en
Inventor
Jurgen Engel
Bernhard Kutsche
Wolfgang Schumacher
Gerhard Nossner
Ulf Niemeyer
Alfred Olbrich
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of IE922182A1 publication Critical patent/IE922182A1/en
Publication of IE80555B1 publication Critical patent/IE80555B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/091Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Steroid Compounds (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)

Abstract

Process for the preparation of C14-C18-alkylphosphocholines in a one-pot process by reaction of an n-alkanol having a chain length of C14-C18 with phosphorus oxychloride in an inert solvent or else without solvent in the presence or absence of a basic substance, and further reaction of the reaction product in an inert solvent with a choline salt in the presence of a basic substance to give the phosphoric acid diester chloride, followed by hydrolysis and isolation of alkylphosphocholine, and, if appropriate, purification by means of a mixed-bed ion exchanger or in succession with an acidic ion exchanger and a basic ion exchanger.

Description

A process for the preparation of alkvlphosphocholines and the production thereof in pure form Eibl et al. (EP 225,608) describe the preparation and use of 5 alkylphosphocholines for the treatment of tumours.
The starting substances used in the Eibl process of preparation are the n-alcohol and phosphorus oxychloride. They are reacted to phosphoric acid ester dichloride in tetrahydrofuran.
In a second step 2-aminoethanol is reacted with the phosphoric acid ester dichloride to 2-hexadecyl-1,3,2-oxaphospholan-2oxide in dioxan. Hydrolysis with 2N hydrochloric acid yields the open-chain amine which is exhaustively methylated to alkylphosphocholine with dimethyl sulphate in 2-propanol.
This process has the following disadvantages: it is necessary to isolate and purify the intermediate products. In addition, alkylating reagents are used. The use of potassium carbonate as an auxiliary base in this step of the process leads to the product having a potassium content that is undesirably high for pharmaceutical purposes.
Long-chain alkylphosphocholines having an antimicrobial effect are described by Kanetani et al., Nippon Kayaku Kaushi, 9, 1452 (1984).
They are prepared using the following process: ethylene glycol and phosphorus trichloride are reacted to form 2-chloro-l,3,2-dioxaphospholane, the product purified by distillation is oxidized with oxygen to 2-chloro-l,3,2-dioxaphospholane-2-oxide and then distilled again. The 2-chloro-l,3,2-dioxaphospholane-2-oxide is then reacted with 1-hexadecanol to 2-hexadecyl-l,3,2-dioxaphospholane-2-oxide . The 2-hexadecyl-l,3,2-dioxaphospholane-2-oxide is reacted with trimethylamine in the autoclave to hexadecylphosphocholine, the raw product is purified both with alkaline and with acid ion exchangers and recrystallized from acetone/chloroform. The analogous process is also used to prepare the octyl-, decyl-, IE 922182 dodecyl, tetradecyl and octadecyl derivatives.
The disadvantage of this process is that it is necessary to work with increased pressure in the last step of the process and that the use of trimethylamine constitutes an industrial hygiene problem in the technical preparation of the substance. It is also a disadvantage that the hydrolysis-sensitive intermediate products 2-chloro-l,3,2-dioxaphospholane, 2-chloro-l,3,2-dioxaphospholane-2-oxide and 2-hexadecyl-2-oxa10 1,3,2-dioxaphospholane need to be isolated and purified. In addition, environmentally-unfriendly solvents such as benzene are used, the solvents being changed from step to step.
All known processes use chromatographic methods for working up and purifying the raw products.
However, chromatographic working up processes of this kind have the following disadvantages: their conversion to a technical scale causes difficulties since the dimensions of the stationary phase cannot be increased at will, chromatographic processes are time-consuming.
The invention relates to a new, advantageous method of preparing and working up alkylphosphocholines.
It has surprisingly been found that the process of the invention achieves a higher total yield, despite the use of one less purification step than in previously known processes. In addition, the invention uses less solvent.
The process of the invention also avoids the use of alkylating reagents such as dimethyl sulphate which lead to a high potassium content of the product due to the use of potassium carbonate as an auxiliary base. The potassium content must be kept as low as possible in substances used as pharmaceutically active substances.
The process of the invention avoids the time-consuming chromatographic step during working up.
The product purity achieved in the process claimed is greater 5 than in the known processes.
The first step in the conversion consists of the reaction of phosphorus oxychloride, optionally in the presence of halogenated hydrocarbons, saturated cyclic ethers, acyclic ethers, saturated hydrocarbons with 5 to 10 carbon atoms, liquid aromatic hydrocarbons which can also be substituted by halogen (in particular chlorine) or mixtures of the above mentioned solvents, and optionally in the presence of a basic substance conventionally used for this purpose, with an n-alkanol having a chain length of 14-18 hydrogen atoms.
Halogenated hydrocarbons that may for example be used are hydrocarbons of 1 to 6 carbon atoms, where one or several or all of the hydrogen atoms are replaced by chlorine atoms. It is for example possible to use methylene chloride, chloroform, ethylene chloride, chlorobenzene, dichlorobenzene. When halogen-substituted aromatic hydrocarbons are used, these are preferably substituted with 1 or 2 halogen atoms.
Saturated cyclic ethers that may be used are for example ethers with a ring size of 5-6 which consist of carbon atoms and 1 or 2 oxygen atoms.
Examples thereof are tetrahydrofuran and dioxan. 0 The acyclic ethers consist of 2 to 8 carbon atoms and are liquid. Examples that may be considered: diethylether, diisobutylether, methyl-tert.-butylether, diisopropyl ether.
Saturated hydrocarbons that may be considered are unbranched and branched hydrocarbons that consist of 5 to 10 carbon atoms and are liquid. Examples that may be considered are pentane, hexane, heptane, cyclohexane.
Aromatic hydrocarbons that may for example be considered are benzene and alkyl-substituted benzenes where the alkyl substituents consist of 1 to 5 carbon atoms.
Basic substances that may be considered both for the reaction of the phosphorus oxychloride with the n-alkanol and also for the subsequent reaction with the choline salt are amines, for example aliphatic amines of the formula NR1R2R3, where Rlf R2 and R3 are the same or different and represent hydrogen or C-j^-Cg-alkyl, aromatic amines such as pyridine, picoline, quinoline.
During the reaction with the choline salt it is possible to add the basic substance required herefor at the same time as the choline salt or before the choline salt. For the reaction with the choline salt a solvent is needed in any case; in other words, if the first reaction step is conducted without a particular solvent, one has to be added at this stage. The mol ratio of phosphorus oxychloride to the alkanol is for example between 1,5:1 to 1:1.1.
The choline salt is for example used in excess in relation to the alkanol (about 1.1 - 1.5 molar excess).
If the reaction of the phosphorus oxychloride with the alkanol occurs in the presence of a basic substance, the amount of the basic substance is for example 1 to 3 Mol related to 1 Mol POC13.
For the subsequent reaction with the choline salt the amount of basic substance used is for example 1 to 5 Mol related to 1 Mol alkanol.
The reaction temperature of the reaction of phosphorus oxychloride with n-alkanol lies between -30°C and +30°C, preferably -15°C and +5°C, in particular -10°C and -5°C.
The reaction time of this conversion is for example 0.5-5 hours, preferably 1-3 hours, in particular 1.5-2 hours. If the reaction occurs in the presence of a basic substance, it is generally quick (about 30 minutes).
The choline salt is then added in portions or in its entirety.
Salts of choline that may for example be used are salts with mineral acids (such as sulphuric acid, hydrochloric acid), and also salts of choline with organic acids such as acetic acid, para-toluenesulphonic acid and the like.
This reaction step occurs in an inert solvent. Solvents that 10 may be considered here are the same that are used to react the phosphorus oxychloride with the n-alkanol if this reaction occurs in a solvent.
The basic substance is then dissolved in one of the stated 15 solvents or added dropwise without solvent.
The following are preferably used as solvent for the basic substance: halogenated hydrocarbons, saturated cyclic ethers, acyclic ethers, saturated hydrocarbons with 5 to 10 carbon atoms, liquid aromatic hydrocarbons or mixtures of the above mentioned solvents.
These are the same solvents that may be used for the reaction of phosphorus oxychloride with the n-alkanol.
Addition of the basic substance causes the temperature to rise. 25 Care must be taken that the temperature is maintained within a range between 0°C to 40°C, preferably 10°C to 30°C, in particular at 15°C to 20°C.
The reaction mixture is then still stirred at 5°C to 30°C, 30 preferably 15°C and 25°C (for example 1 hour to 40 hours, preferably 3 hours to 15 hours).
The hydrolysis of the reaction mixture occurs through addition of water, it being necessary to maintain a temperature between °C and 30°C, preferably 15°C and 30°C, in particular between °C and 20°C.
The previously mentioned hydrolysis liquids can also contain basic substances. Basic substances that may be considered include carbonates and hydrogen carbonates of the alkaline and alkaline earth metals.
To complete the hydrolysis the mixture is then stirred for a further 0.5 hours to 4 hours, preferably 1 to 3 hours, in particular 1.5 to 2.5 hours at 10°C to 30°C, preferably at 15°C to 25°C, in particular at 18°C to 22°C.
The reaction solution is then washed with a mixture of water and alcohols (preferably aliphatically saturated alcohols with 1 to 4 carbon atoms) which may optionally also contain a basic substance.
The mixing ratio water:alcohol may for example lie between 5 and 0.5, preferably 1-3 (V/V).
Basic substances that may be considered as washing liquid are for example carbonates and hydrogen carbonates of the alkaline and alkaline earth metals as well as ammonia in the form of the aqueous solution. A 3% sodium carbonate solution in water is particularly preferred.
It is then optionally possible to wash the reaction solution with an acid solution.
Acid washing is advantageous to remove not yet reacted basic portions of the reaction solution, in particular when methylene chloride is used as solvent.
The washing solution consists of a mixture of water and alcohols. Mixtures of aliphatically saturated alcohols with 1 to 4 carbon atoms are preferably used, an acid substance also optionally being present. The mixing ratio water: alcohol may for example lie between 5 and 0.5, preferably 1-3 (V/V).
Acid substances that may be considered for the washing liquid are for example mineral acids and organic acids, for example hydrochloric acid, sulphuric acid or tartaric acid, and citric acid.
A 10% solution of hydrochloric acid in water is particularly preferred.
The mixture is then washed one again with a mixture of water and alcohols. Mixtures of aliphatic saturated alcohols with 1 to 4 carbon atoms are preferably used, it also being possible for a basic substance to be optionally present.
The mixing ratio water: alcohol may for example lie between 5 and 0.5, preferably 1-3.
The washed phases are then combined and dried in conventional manner and the solvent is then removed (preferably under reduced pressure, for example 5-100 mbar) optionally after addition of 1.5-3 litres, preferably 2-2.5 litres of an aliphatic alcohol (related to 1 part by weight of dried product). Alcohols that may for example be used are saturated aliphatic alcohols with a chain length of 1 and 5 carbon atoms.
The particularly preferred alcohol here is n-butanol, isopropanol. The purpose of this alcohol treatment is to remove the residual water completely.
The product so-obtained can be purified in the conventional manner (e.g. by chromatography, recrystallization).
An alkylphosphocholine raw product or the solid residue as described above is for example suspended in saturated aliphatic ketones (3-6 carbon atoms), for example acetone, butanone, methyl-tert.-butylketone, stirred for 1 to 4 hours, preferably 2 hours, suction filtered and dried at 20°C to 50°C in a vacuum at 5 Torr to 100 Torr.
The following purification process is, however, particularly preferred: The product prepurified in this manner is taken up in anhydrous alcohols (C3 to C4) or in alcohols which contain not more than up to 5 percent by weight of water at 20°C to 60°C, preferably 40°C and insoluble constituents filtered off.
Alcohols that may for example be used are methanol, ethanol, 5 isopropanol, butanol, isobutanol.
The prepurified product may also be dissolved in water.
The filtrate obtained is then stirred with a mixed-bed ion exchanger, for example AmberliteR MB3 , for example for 1 to 5 hours, preferably 2 hours at 10°C to 50°C, preferably 20°C.
Instead of a mixed-bed ion exchanger the purification may also be effected simultaneously or successively with an acid ion exchanger and a basic ion exchanger.
Ion exchangers which may also be used are all insoluble solids which contain ion exchanging groups.
Acid ion exchangers are those which contain for example acid groups such as sulphonic acid groups, carboxyl groups. Examples are ion exchangers with sulphonic acid groups in a polystyrene matrix such as AmberliteR IR 120, DowexR HCR, DuoliteR C 20 or LewatitR S 100.
Weakly acid ion exchangers are for example those which carry carboxylic acid groups on the basis of a polyacrylic acid matrix, such as AmberliteR IRC 76, DuoliteR C 433 or ReliteR CC.
Basic ion exchangers that may for example be considered are those carrying on a polymer matrix (e.g. polystyrene matrix) primary, secondary, tertiary or guaternary amino groups such as DuoliteR A 101, DuoliteR A 102, DuoliteR 15 A 348 :, DuoliteR A 365, DuoliteR A 375, AmberliteR IRA 67, DuoliteR A 375, AmberliteR IRA 458 and DuoliteR A 132.
Mixed-bed ion exchangers are mixtures of acid and alkaline ion exchanger resins, such as AmberliteR MB1, AmberliteR MB2, AmberliteR MB3 and AmberliteR MB6.
It is also possible to use all conventional ion exchangers in the process.
Reference is also made to Ullmann's Encyclopedia of Industrial Chemistry, 5th Edition (1989), Volume A14, p. 450.
Following vacuum suctioning of the ion exchanger resin the mixture is evaporated under reduced pressure (for example 20 Torr to 200 Torr) at 40°C to 70°C and the mixture is then recrystallized from halogenated hydrocarbons or from alcohol/ketone mixtures.
Halogenated hydrocarbons that may for example be considered for the recrystallization are hydrocarbons containing 1 to 6 carbon atoms where one or several or all carbon atoms are replaced by chlorine atoms.
It is for example possible to use methylene chloride, chloroform, ethylene chloride, chlorobenzene.
Alcohols that may be considered are saturated aliphatic alcohols with 1 to 6 carbon atoms and 1 to 2 hydroxyl groups. Ketones that may be considered are saturated, aliphatic ketones with 3 to 8 carbon atoms.
The mixing ratio alcohol:ketone is 1 to 1-5 (volume/volume). An ethanol/acetone mixture in the ratio of 1:1 (V/V) is particularly preferred.
The crystals of alkylphosphocholine obtained are suction filtered and if necessary washed for example with saturated hydrocarbons containing 1 to 6 carbon atoms. (Temperature of the washing liquid for example 15 to 30°C).
Drying is effected for example in a vacuum at 40°C to 80°C over conventional drying agents, for example phosphorus pentoxide or silica gel.
Example 1 Preparation of hexadecvl phosphocholine 1.0 Mol (92 ml) POC13 in 1.5 1 chloroform are added to a 6-litre stirring apparatus under nitrogen and cooled in an ice bath to 5°C. 0.90 Mol (218 g) hexadecanol are dissolved in 700 ml chloroform and added dropwise together with 4.00 Mol (320 ml) pyridine at a temperature of 5 - 12°C. Dropping time: 1.25 hours. The dropping funnel is then flushed with the remaining 300 ml chloroform. After one and a half hours post-stirring at 0 - 5°C, 1.35 Mol (372 g) solid choline tosylate are added and then 400 ml pyridine added dropwise over 15 minutes. This causes the temperature to rise to 2 0°C. The ice bath is removed and the reaction mixture is stirred at room temperature for 3 hours. For purposes of hydrolysis 150 ml water are added dropwise over 2 0 minutes, the temperature rising from 25°C to 36°C. After stirring for half an hour, the reaction solution is washed in each case once with 1.50 litres water/methanol (1:1), 1.50 litres 3% sodium carbonate/methanol (1:1) and 1.50 litres water/methanol (1:9). The chloroform phase washed in this manner is dried over sodium sulphate and evaporated in a rotary evaporator in a vacuum after addition of 50 ml i-propanol. n-butanol is added for drying and the mixture is evaporated in a rotary evaporator again.
Purification is carried out as follows: The residue is suspended in 2.0 litres acetone, stirred for approx. 2 hours, suction filtered and dried at 30°C in a vacuum. Raw yield: 325 g (87 %) . The raw product is taken up in 3.0 litres absolute ethanol and insoluble portions filtered off. The filtrate is stirred for two hours with 1.0 litres mixed-bed ion exchanger Amberlite MB 3R(FLUKA). After suction filtration of the ion exchanger resin the mixture is evaporated in a rotary evaporator in a vacuum and then recrystallized once from 0.70 litres methylene chloride. Complete crystallization is achieved in the refrigerator. The crystals are suction filtered and washed with pentane. The mixture is then dried in a vacuum at 3 0°C over phosphorus pentoxide.
Yield 193 g (0.47 Mol, 53 %) The reaction product has a melting point of 241 - 245°C.
Examples 2-5 are prepared according to the same procedure.
Example 2: 0 II ® D-19390: H3C-(CH2)13-0-P-0-(CH2)2~N(CH3)3 ιθ Mp: 260°C (disintegration) C19H42NO4P (379.52) TL: 89 a (chloroform/methanol/ammonia 25% =70:20:10) Rf:0.27 EA: calc. C 60.13% H 11.16% N 3.69% *h2o 57.41% 11.16% 3.52% found C 57.40% H 11.42 N 3.61% 57.43% 11.47% 3.65% 'H-NMR: (250 MHz, CDC13) = 0.90 ppm (t,3H) 3.80 25 (m,22H) 3.85 (m,2H) 55 (p,2H) 4.25 (m,2H) 3.40 (s,9H) D-20403 : H3C- (CH2)14-0-P-0-(CH2)2-N(CH3)3 ϊθ Example 3: Mp: 244°C (disintegration) c20H44NO4P (393.55) TL: 89 a (chloroform/methanol/ammonia 25% =70:40:10) Rf :0.49 EA: calc. C 61.04% H 11.27% N 3.56% *2H2O 55.92% 11.26% 3.26% found C 56.14% H 10.99 N 3.67% 55.74% 10.85% 3.59% 'H-NMR: (250 MHz, CDC13) = 0.90 ppm (t,3H) 3.80 30 (m,24H) 3.85 (m,2H) 55 (P,2H) 4.25 (m,2H) 40 (s,9H) (q,2H) Example 4: O 0 || Φ D-19767: H3C-(CH2)16-O-P-O-(CH2)2-N(CH3)3 Mp: 254 - 256°C C22H48NO4P (421.61) TL: 127 c (I-butanol/glacial acetic acid/water=60:20:20) Rf:0.34 EA: calc. C 62.68% H 11.48% N 3.32% 40 ,H20 60.11% 11.46% 3.19% found C 60.2% H 11.7 N 3.1% 60.5% 11.7% Ή-NMR: (250 MHz, CDC13) ί = 0.90 ppm (t,3H) 3.80 (q,2H) 1.25 (m,28H) 3.85 (m,2H) 1.60 10 (p,2H) 4.25 (m,2H) 3.40 (s,9H) Example 5: 0 D-19391: H3C-(CH2)17-O-P-O-(CH2)2-N(CH3)3 i® Mp: 258°C (disintegration) C23H50NO4P (435.62) TL: 126 (I-butanol/glacial acetic acid/water=40:10:10) Rf :0.13 25 EA: calc. *h2o found C 63.41% 60.90% C 60.80% 60.83% H 11.57% 11.55% H 11.93 12.02% N 3.22% 3.09% N 3.15% 3.15% 'H-NMR: (250 δ = 0.90 ppm 1.25 (m,30H) 1.60 (P,2H) 3.40 (s,9H) MHZ, CDC13) (t,3H) 3.80 (q,2H) 3.85 (m,2H) 4.30 (m,2H)

Claims (4)

1. A process for the preparation of C 14 -C 18 -alkylphospho5 cholines which comprises reacting an n-alkanol with phosphorus oxychloride and a choline salt, characterized in that an n-alkanol with a chain length of C 14 -C 18 is reacted with phosphorus oxychloride, optionally in the presence of an inert solvent, in the presence or absence 10 of a basic substance in a single vessel process, the product obtained being further reacted without isolation and purification in an inert solvent with a choline salt in the presence of a basic substance to form phosphoric acid diester chloride, the alkylphosphocholine then being 15 liberated and isolated by subsequent hydrolysis.
2. A purification process for alkylphosphocholines characterized in that a solution of alkylphosphocholines is prepared, using conventional processes or the process 20 according to claim 1, and treated in an organic agent with a mixed-bed ion exchanger or successively with an acid ion exchanger and a basic ion exchanger.
3. A process for the preparation of C 14 -C 18 -alkyl25 phosphocholines, characterized in that the reaction temperature lies between O’C and 40°C. •Ε 922182 5. 5. 6. 6. 7. 7. A process according to Claim 1 or 3 for the preparation of a C-| 4-C1 g-alkylphosphochline, substantially as hereinbefore described and exemplified. A Ci4-C1g-alkylphosphochline, whenever prepared by a process claimed in any one of Claims 1, 3 or
4. A purification process according to Claim 2, substantially as hereinbefore described and exemplified. A purified alkylphosphocoline whenever obtained by a process claimed in Claim 2 or 6.
IE922182A 1991-07-04 1992-07-03 A process for the preparation of alkylphosphocholines and the production thereof in pure form IE80555B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4122127 1991-07-04

Publications (2)

Publication Number Publication Date
IE922182A1 true IE922182A1 (en) 1993-01-13
IE80555B1 IE80555B1 (en) 1998-09-23

Family

ID=6435410

Family Applications (1)

Application Number Title Priority Date Filing Date
IE922182A IE80555B1 (en) 1991-07-04 1992-07-03 A process for the preparation of alkylphosphocholines and the production thereof in pure form

Country Status (19)

Country Link
EP (1) EP0521297B1 (en)
JP (1) JP3171279B2 (en)
CN (1) CN1034941C (en)
AT (1) ATE158295T1 (en)
AU (2) AU652646B2 (en)
CA (1) CA2073126C (en)
DE (2) DE59208905D1 (en)
DK (1) DK0521297T3 (en)
EG (1) EG20551A (en)
ES (1) ES2108715T3 (en)
FI (1) FI107260B (en)
GR (1) GR3025490T3 (en)
HU (1) HU219243B (en)
IE (1) IE80555B1 (en)
IL (1) IL102379A (en)
NO (2) NO304232B1 (en)
PL (1) PL169571B1 (en)
SG (1) SG47844A1 (en)
ZA (1) ZA924980B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0521353T3 (en) * 1991-07-04 1996-05-13 Asta Medica Ag Antineoplastic drug containing octadecyl (2- (N-methylpiperidino) ethyl) phosphate as an active ingredient and process for its preparation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3164332D1 (en) * 1980-10-21 1984-07-26 Boehringer Mannheim Gmbh Phospholipids that contain sulphur, process for their preparation and medicines containing these compounds
JPS60184092A (en) * 1984-03-01 1985-09-19 Kao Corp Phosphoric ester and its preparation
IE59778B1 (en) * 1985-12-04 1994-04-06 Max Planck Gesellschaft Medicament with anti-tumour action containing hexadecylphosphocholine
EP0336142A3 (en) * 1988-04-04 1991-04-24 American Cyanamid Company Novel antagonists of platelet activating factor
IT1229238B (en) * 1989-05-08 1991-07-26 Istituto Chemioterapico PROCEDURE FOR THE PREPARATION OF L-ALPHA-GLYCERYLPHOSPHORYLCHOLINE AND ALPHA-GLYCERYLPHOSPHORYLETHANOLAMINE.

Also Published As

Publication number Publication date
EP0521297A1 (en) 1993-01-07
DE59208905D1 (en) 1997-10-23
FI107260B (en) 2001-06-29
ES2108715T3 (en) 1998-01-01
NO922612L (en) 1993-01-05
IL102379A0 (en) 1993-01-14
DE4220852A1 (en) 1993-01-14
NO981742D0 (en) 1998-04-17
IL102379A (en) 1996-10-31
GR3025490T3 (en) 1998-02-27
SG47844A1 (en) 1998-04-17
FI923087A (en) 1993-01-05
JP3171279B2 (en) 2001-05-28
ZA924980B (en) 1993-04-28
CN1034941C (en) 1997-05-21
FI923087A0 (en) 1992-07-03
PL169571B1 (en) 1996-08-30
EP0521297B1 (en) 1997-09-17
CN1068331A (en) 1993-01-27
IE80555B1 (en) 1998-09-23
CA2073126C (en) 2001-09-04
AU652646B2 (en) 1994-09-01
CA2073126A1 (en) 1993-01-05
AU6605994A (en) 1994-09-22
NO304316B1 (en) 1998-11-30
DE4220852C2 (en) 2000-10-19
EG20551A (en) 1999-07-31
HUT61560A (en) 1993-01-28
DK0521297T3 (en) 1998-05-04
AU1944192A (en) 1993-01-07
HU9202233D0 (en) 1992-10-28
NO981742L (en) 1993-01-05
HU219243B (en) 2001-03-28
PL295129A1 (en) 1993-06-28
JPH05186483A (en) 1993-07-27
NO304232B1 (en) 1998-11-16
AU663259B2 (en) 1995-09-28
ATE158295T1 (en) 1997-10-15
NO922612D0 (en) 1992-07-02

Similar Documents

Publication Publication Date Title
US5942639A (en) Process for the preparation of alkylphosphocholines and the production thereof in pure form
IL35343A (en) Process for the preparation of haloethyl phosphonic acids
IE48781B1 (en) Fosfomycin derivatives
IE922182A1 (en) A process for the preparation of alkylphosphocholines and¹the production thereof in pure form
EP1370565B1 (en) Method of producing 1-hydroxy-1,1-diphosphonic acid compounds
EP0521353B1 (en) Antineoplastic medicament containing octadecyl-[2-(N-methylpiperidino)-ethyl] phosphate and synthesis thereof
JPH0892263A (en) Production of phosphoric monoester
WO2007083243A2 (en) An improved process for the preparation of risedronate sodium hemi-pentahydrate
JP3688304B2 (en) Phospholipid derivative, method for producing the derivative, purification method for the derivative, pharmaceutical product containing the derivative, and method for producing the pharmaceutical product
US4740609A (en) Phosphoric esters and process for preparing same
US2361286A (en) Phosphoric acid esters of glycerol ethers and their manufacture
US5958906A (en) Phospholipid derivatives containing higher elements of the fifth main group
EP0091078B1 (en) A process for the preparation of derivatives of 2-diethylamino-1-methyl ethyl cis-1-hydroxy-(bicyclohexyl)-2-carboxylate
JP2649343B2 (en) Method for producing phosphate ester
US4279838A (en) Process for the preparation of aminoaryl thiophosphates and aminoaryl phosphates
JP2000178288A (en) Production of phosphoric triester
JPH04282390A (en) Production of phosphoric diester
JPS62258392A (en) Ammonium monofluorophosphate and its production
JPS61229888A (en) Production of phosphoric acid ester

Legal Events

Date Code Title Description
MK9A Patent expired